Literature DB >> 19641675

Evaluation of serum neopterin, high-sensitivity C-reactive protein and thiobarbituric acid reactive substances in Egyptian patients with acute coronary syndromes.

M Ragab1, H Hassan, T Zaytoun, W Refai, B Rocks, M Elsammak.   

Abstract

The present study evaluated serum neopterin, high-sensitivity C-reactive protein (hs-CRP) and thiobarbituric acid reactive substances (TBARS) in Egyptian patients with acute coronary artery disease. Thirty-six patients with unstable angina aged (mean +/- SD) 61.3+/-9.4 years, 29 patients with myocardial infarction aged 58.2+/-8.7 years and 24 sex- and age-matched control subjects were included in the study. Neopterin levels were significantly higher in patients with myocardial infarction and those with unstable angina than in the healthy control group (P<0.001). The serum level of neopterin in the control group (median [range]) was 3.25 nmol/L (1.25 nmol/L to 5.4 nmol/L), whereas in patients with unstable angina and those with myocardial infarction, neopterin levels were 10.4 nmol/L (3.5 nmol/L to 15.2 nmol/L) and 12.6 nmol/L (3.25 nmol/L to 17.8 nmol/L), respectively. Levels of hs-CRP and TBARS were also significantly higher in patients with unstable angina and those with myocardial infarction than in the healthy control group (P<0.01). The medians (ranges) of hs-CRP were 4.8 mg/L (2.5 mg/L to 9.9 mg/L), 12.0 mg/L (4.6 mg/L to 31.0 mg/L) and 12.3 mg/L (7.5 mg/L to 32.1 mg/L) in the control group, patients with unstable angina and those with myocardial infarction, respectively. The means +/- SD of TBARS in the control group, patients with unstable angina and those with myocardial infarction were 0.64+/-0.17 mumol/L, 1.17+/-0.31 mumol/L and 1.17+/-0.49 mumol/L, respectively. TBARS positively correlated with hs-CRP and neopterin levels. Furthermore, when both patients and controls were classified according to their smoking status, significantly higher levels of neopterin and TBARS were found in the smokers of each subgroup than in the nonsmokers.In conclusion, the present study found a higher level of neopterin, hs-CRP and TBARS in patients with coronary artery disease. Serum neopterin and hs-CRP positively correlated with the level of TBARS. The authors suggest that triggering factors (eg, smoking, high cholesterol, elevated body mass index or raised blood pressure) may lead to increased oxidative stress, which induces an inflammatory insult leading to higher levels of inflammatory markers such as neopterin and hs-CRP.

Entities:  

Keywords:  CAD; Neopterin; Oxidative stress; TBARS; hs-CRP

Year:  2005        PMID: 19641675      PMCID: PMC2716238     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  45 in total

1.  Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia.

Authors:  D Ferro; S Parrotto; S Basili; C Alessandri; F Violi
Journal:  J Am Coll Cardiol       Date:  2000-08       Impact factor: 24.094

2.  PON1 activities and oxidative markers of LDL in patients with angiographically proven coronary artery disease.

Authors:  Elif Azarsiz; Meral Kayikcioglu; Serdar Payzin; Eser Yildirim Sözmen
Journal:  Int J Cardiol       Date:  2003-09       Impact factor: 4.164

3.  Elevated plasma lipid peroxide levels in angina pectoris and myocardial infarction.

Authors:  Diana A Gorog; Nabeel Ahmed; Graham J Davies
Journal:  Cardiovasc Pathol       Date:  2002 May-Jun       Impact factor: 2.185

4.  Platelet activation in obese women: role of inflammation and oxidant stress.

Authors:  Giovanni Davì; Maria Teresa Guagnano; Giovanni Ciabattoni; Stefania Basili; Angela Falco; Marina Marinopiccoli; Michele Nutini; Sergio Sensi; Carlo Patrono
Journal:  JAMA       Date:  2002 Oct 23-30       Impact factor: 56.272

5.  Correlates of markers of oxidative status in the general population.

Authors:  M Trevisan; R Browne; M Ram; P Muti; J Freudenheim; A M Carosella; D Armstrong
Journal:  Am J Epidemiol       Date:  2001-08-15       Impact factor: 4.897

Review 6.  Interactions of oxidants with vascular signaling systems.

Authors:  M S Wolin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-06       Impact factor: 8.311

7.  Serum neopterin and activity of coronary artery disease.

Authors:  J Auer; R Berent; E Labetanig; B Eber
Journal:  Heart Dis       Date:  2001 Sep-Oct

8.  Neopterin as a marker of immunostimulation: an investigation in anaesthetic workplaces.

Authors:  G Gruber; P Lirk; A Amann; C Keller; W Schobersberger; G Hoffmann; D Fuchs; J Rieder
Journal:  Anaesthesia       Date:  2002-08       Impact factor: 6.955

9.  R/R genotype of human paraoxonase (PON1) is more protective against lipoprotein oxidation and coronary artery disease in Japanese subjects.

Authors:  Kenichi Kuremoto; Yoshiro Watanabe; Hirotoshi Ohmura; Kazunori Shimada; Hiroshi Mokuno; Hiroyuki Daida
Journal:  J Atheroscler Thromb       Date:  2003       Impact factor: 4.928

10.  The role of inflammation markers in triggering acute coronary events.

Authors:  Mehmet Tokaç; Ali Ozeren; Murad Aktan; Bülent B Altunkeser; Kurtuluş Ozdemir; Akif Düzenli; Hasan Gök
Journal:  Heart Vessels       Date:  2003-09       Impact factor: 2.037

View more
  2 in total

1.  Oxidative stress in coronary artery bypass surgery.

Authors:  Amaury Edgardo Mont'Serrat Ávila Souza Dias; Petr Melnikov; Lourdes Zélia Zanoni Cônsolo
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Jul-Aug

2.  Neopterin Counters Vascular Inflammation and Atherosclerosis.

Authors:  Remina Shirai; Kengo Sato; Tomoyuki Yamashita; Maho Yamaguchi; Taisuke Okano; Kaho Watanabe-Kominato; Rena Watanabe; Taka-Aki Matsuyama; Hatsue Ishibashi-Ueda; Shinji Koba; Youichi Kobayashi; Tsutomu Hirano; Takuya Watanabe
Journal:  J Am Heart Assoc       Date:  2018-02-02       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.